Literature DB >> 8547123

Thalassaemic erythrocytes: cellular suicide arising from iron and glutathione-dependent oxidation reactions?

M D Scott1, J W Eaton.   

Abstract

Both beta-thalassaemic red blood cells and normal red blood cells (RBC) artificially loaded with unpaired alpha-haemoglobin chains exhibit increased amounts of membrane-bound haem and iron. In the model beta-thalassaemic RBC the amount of free haem and iron was as much as 20 times that which could have been contributed by the entrapped alpha-haemoglobin chains alone. This excess haem/iron arises from destabilization of haemoglobin via reactions between ferric iron (Fe3+), initially contributed by the unpaired alpha chains, and cytoplasmic constituents, primarily reduced glutathione (GSH). Indeed, in the presence of Fe3+ (100 microM) addition of even small amounts of GSH (0.5 mM) to dilute RBC haemolysates (0.15 mg haemoglobin/dl) greatly accelerated methaemoglobin formation. In contrast, lysates from GSH-depleted RBC demonstrated a significantly reduced rate of iron-mediated haemoglobin oxidation which was reversible by addition of GSH. The initiation, and subsequent propagation, of Fe(3+)-mediated haemoglobin oxidation was significantly inhibited by iron chelators. Finally, Fe(3+)-driven haemoglobin oxidation was synergized by low amounts of H2O2, an oxidant spontaneously generated in thalassaemic RBC. To summarize, the release of small amounts of free iron from unpaired alpha-haemoglobin chains in the beta-thalassaemic RBC can initiate self-amplifying redox reactions which simultaneously deplete cellular reducing potential (e.g. GSH), oxidize additional haemoglobin, and accelerate the red cell destruction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547123     DOI: 10.1111/j.1365-2141.1995.tb05394.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload.

Authors:  Xueshan Gao; Mingwei Qian; Jian Li Campian; James Marshall; Zhanxiang Zhou; Andrew M Roberts; Y James Kang; Sumanth D Prabhu; Xiao-Feng Sun; John W Eaton
Journal:  Free Radic Biol Med       Date:  2010-05-05       Impact factor: 7.376

2.  The regulation of erythropoiesis by selenium in mice.

Authors:  Naveen Kaushal; Shailaja Hegde; Jeanne Lumadue; Robert F Paulson; K Sandeep Prabhu
Journal:  Antioxid Redox Signal       Date:  2011-02-25       Impact factor: 8.401

3.  Syk Kinase Inhibitors Synergize with Artemisinins by Enhancing Oxidative Stress in Plasmodium falciparum-Parasitized Erythrocytes.

Authors:  Ioannis Tsamesidis; Karine Reybier; Giuseppe Marchetti; Maria Carmina Pau; Patrizia Virdis; Claudio Fozza; Francoise Nepveu; Philip S Low; Francesco Michelangelo Turrini; Antonella Pantaleo
Journal:  Antioxidants (Basel)       Date:  2020-08-14

4.  FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis.

Authors:  Xin Zhang; Genís Campreciós; Pauline Rimmelé; Raymond Liang; Safak Yalcin; Sathish Kumar Mungamuri; Jeffrey Barminko; Valentina D'Escamard; Margaret H Baron; Carlo Brugnara; Dmitri Papatsenko; Stefano Rivella; Saghi Ghaffari
Journal:  Am J Hematol       Date:  2014-07-22       Impact factor: 10.047

5.  Clinical assay of four thiol amino acid redox couples by LC-MS/MS: utility in thalassemia.

Authors:  Jung H Suh; Robert Kim; Burcu Yavuz; Daniel Lee; Ashutosh Lal; Bruce N Ames; Mark K Shigenaga
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-07-02       Impact factor: 3.205

6.  Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia.

Authors:  Yi Kong; Suiping Zhou; Anthony J Kihm; Anne M Katein; Xiang Yu; David A Gell; Joel P Mackay; Kazuhiko Adachi; Linda Foster-Brown; Calvert S Louden; Andrew J Gow; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

7.  Total Antioxidant Status in Patients with Major β-Thalassemia.

Authors:  Fatemeh Bazvand; Sedigheh Shams; Mahtab Borji Esfahani; Lili Koochakzadeh; Maryam Monajemzadeh; Mohammad-Taghi Haghi Ashtiani; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2011-06       Impact factor: 0.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.